Endobronchial Valve Demonstrates Sustained Improvements for Severe Emphysema
Researchers found 'statistically significant improvements' in lung function, respiratory symptoms, and quality of life measures at 24 months.
Researchers found 'statistically significant improvements' in lung function, respiratory symptoms, and quality of life measures at 24 months.
On November 15th, healthcare organizations across the globe are observing World COPD Day 2023 by emphasizing the importance of early disease detection.
CVS Health is pulling certain oral decongestants from its shelves that contain phenylephrine, an ingredient an FDA panel recently deemed ineffective.
Health Care Originals, a maker of cardiopulmonary wearable systems, acquired Dawn Health’s virtual sleep care platform to accelerate the deployment of its Nightingale virtual care to benefit Americans with asthma or COPD.
A study of current and former smokers found that suspected bronchiectasis is associated with a heightened risk of all-cause mortality, even without the presence of COPD.
Five lung stem cell variants dominate the lungs of patients with advanced cystic fibrosis (CF), and these variants drive key aspects of CF pathology including inflammation, fibrosis, and mucin secretion, according to new research.
The Pulmonary Fibrosis Foundation announced Franck Rahaghi, MD, MHS, FCCP, as its incoming president, CEO, and chief medical officer, effective Sept 15.
An FDA advisory committee determined that phenylephrine, common in brands like Benadryl and Mucinex, is ineffective as a nasal decongestant.
A new study finds that idrevloride in hypertonic saline is safe and associated with a significant improvement in lung function in individuals with primary ciliary dyskinesia when compared to hypertonic saline alone.